US Patent 7674904 Synthesis of R-N-methylnaltrexone

Patent 7674904 was granted and assigned to Progenics Pharmaceuticals on March, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Progenics Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7674904

Date of Patent

March 9, 2010

Patent Application Number

11441395

Date Filed

May 25, 2006

Patent Citations Received

‌

US Patent 12017026 Drug delivery device and methods for using same

Patent Primary Examiner

‌

Charanjit S. Aulakh

Patent abstract

This invention relates to stereoselective synthesis of R-MNTX and intermediates thereof, pharmaceutical preparations comprising R-MNTX or intermediates thereof and methods for their use.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7674904 Synthesis of R-N-methylnaltrexone

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API